The drug is designed to selectively kill cancer cells by targeting the enzymes involved in a process called “myristoylation.”
Specialists of the University of Alberta developed a new drug that would have the potential to become one of the potential ways to treat cancer of mama and that of blood. This medicine is called PCLX-001 And it is made to selectively destroy cancer cells by targeting enzymes that have a lot to do with the development of this disease.
How does this drug that could become one of the new ways to treat cancer?
–
You can read: How do dogs help treat Cancer childish?
Ways to treat cancer: develop medicine that could become new treatment
The University of Alberta points in a publication on their website that the drug PCLX-001 is designed to selectively kill cancer cells by targeting the enzymes involved in a process called “myristoylation“, which is key to the cellular signaling system that often does not work as it should when you have this condition.
It should be noted that the initial idea was not theirs, since the Canadian educational institution points out that the molecule was originally developed by elements of the Dundee University as a treatment from african sleeping sickness.
The Centers for Disease Control and Prevention (CDC) they mention that african sleeping sickness is caused by a Moscow call “Tsetsé“found only in rural areas of Africa and it can cause fever, swollen lymph nodes, irritability, severe headaches, extreme fatigue, and pain in the muscles and joints.
The cell biologist of the University of Alberta, Luc Berthiaume, was the first to realize that the molecule could work against Cancer.
John Mackey, the first author of the research, commented than your drug, which could become one of the ways to treat cancer, is scheduled to begin volunteer trials this year.
“Our findings provide further rationale and rationale for starting the clinical trial in May. This is another very exciting step in finding out if it will be one of the ways to treat cancer“, Indian Mackey.
You may also like: Inexpensive trial could save the lives of patients with Cancer colon
The team of Mackey examined the tumors of more than 700 women who had participated in a worldwide study for another drug in 1998 and found that all neoplasms contained one thing in common: the enzyme N-myristoyltransferase 2 and that patients with these tumors had a higher risk of losing their lives in the next decade.
PCLX-001 it is designed to selectively kill cancer cells and has not yet been tested in humans. However, it slowed tumor growth by 90% in mice with Cancer breast cancer and the findings were similar against lymphomas, which are a type of Cancer of the blood.
This drug is expected to be tested in humans in the coming months and if successful, it could be considered as one of the new ways to treat cancer.
–
Related
